Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2.

Created on 18 Aug 2026

Authors

Manish A Shah, Jacob S Marzalik, Erin B Kennedy, Dana Deighton, Zahra Hamedi, Minaxi Jhawer, Kunal C Kadakia, Paola Montenegro, Sarbajit Mukherjee, Christopher Nevala-Plagemann, Anwaar Saeed, Bryan J Schneider, Thomas Semrad, Kohei Shitara, Melani Vincelli, Lakshmi Rajdev

Published in

Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Pages 101200JCO2601944. Aug 17, 2026. Epub Aug 17, 2026.

Abstract

[Box: see text]Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual. ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines. Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix I and Appendix II). Updates are published regularly and can be found on the ASCO Publications website.

PMID:
42607281
Bibliographic data and abstract were imported from PubMed on 18 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement